Sulindac
- Product NDC
- 0378-0531
- 11-digit product format
- 003780531
- Labeler code
- 0378
- Product ID
- 0378-0531_038acf5f-64ac-423c-aeb5-b3f2ae9014d0
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- sulindac
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Mylan Pharmaceuticals Inc.
- Application
- ANDA073039
- Marketing category
- ANDA
- Marketing start
- 1993-06-22
- Marketing end
- 2021-06-30
- Substance
- SULINDAC
- Active strength
- 200 mg/1
- Pharmacologic classes
- Cyclooxygenase Inhibitors [MoA],Anti-Inflammatory Agents, Non-Steroidal [CS],Nonsteroidal Anti-inflammatory Drug [EPC]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0378-0531-01 | 00378053101 | 100 TABLET in 1 BOTTLE, PLASTIC (0378-0531-01) | 100 tablet | 1993-06-22 | 2021-06-30 | No | No | Current |